You can buy or sell SLP and other stocks, options, ETFs, and crypto commission-free!
Simulations Plus, Inc. engages in licensing and conducting drug research by pharmaceutical and biotechnology companies. It offers pharmaceutical, and chemical, cosmetics and food industries. Read More The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered Lancaster, CA.
52 Week High
52 Week Low
Simply Wall St2h
Are Insiders Selling Simulations Plus, Inc. (NASDAQ:SLP) Stock?
We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we’d be remiss not to mention that insider sales have been known to precede tough periods for a business. So before you buy or sell Simulations Plus, Inc. (NASDAQ:SLP), you may well want to know whether insiders have been buying or selling. What Is Insider Buying? Most investors know that it is quite permissible for company leaders, such as directors of the board, to buy and sell stock on the marke...
Stock Price, News, & Analysis for Simulations Plus
Simulations Plus, Inc. develops drug discovery and development software for mechanistic modeling and simulation, and machine-learning-based prediction of properties of molecules from their structure worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), pharmacodynamics, and drug-drug interactions of compounds administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments that measure the rate of dissolution of the drug and additives in a...
Simply Wall StMar 11
Should Simulations Plus, Inc. (NASDAQ:SLP) Be Your Next Stock Pick?
Building up an investment case requires looking at a stock holistically. Today I’ve chosen to put the spotlight on Simulations Plus, Inc. (NASDAQ:SLP) due to its excellent fundamentals in more than one area. SLP is a company with great financial health as well as a an impressive history of performance. Below is a brief commentary on these key aspects. For those interested in digger a bit deeper into my commentary, read the full report on Simulations Plus here. Flawless balance sheet with solid track record...
Expected Apr 8, After Hours